Jiang, Zhuolin
Pu, Wei
Luo, Xinyi
Zhang, Jie
Jia, Shijun
Zhang, Guonan
Zhu, Yi
Funding for this research was provided by:
China-Japan Sasakawa Medical Fellowship (2021-111)
Postdoctoral Science Foundation of Guangxi Province of China (2023M730510)
the Sichuan Key Research and Development Project from the Sichuan Provincial Science and Technology Department (2023YFS0093)
Article History
Received: 4 June 2025
Accepted: 24 July 2025
First Online: 30 July 2025
Declarations
:
: The requirement for obtaining written informed consent from the patients was waived.
: The authors declare no competing interests.
: OCC-US model for ovarian mass differentiation.
: This retrospective diagnostic study was reviewed and approved by the Ethics Committee of Sichuan Cancer Hospital (Ethics No.: SCCHEC022019025).
: 1Department of Ultrasound, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China (UESTC), Chengdu 610041, China.2Department Gynecologic Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China (UESTC), Chengdu 610041, China.3Department of Pathology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China (UESTC), Chengdu 610041, China.